This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines include a pair of aerospace upgrades for European Aeronautic Defence and Space Company (NASDAQOTH: EADSY ) and Hexcel (NYSE: HXL ) . But it's not all good news, so let's start off by finding out why.
This analyst doesn't dig Cliffs Natural Resources
Investors in coal and iron miner Cliffs Natural Resources (NYSE: CLF ) are off to a rocky start this week, as analysts at FBR Capital cut their price target on the stock 15% to $28 a share.
Now admittedly, FBR isn't recommending you sell Cliffs. To the contrary, the banker reiterated its overall feeling that the stock's more of a market performer than an actual sell. The big question, though, is why FBR didn't come out and give Cliffs a big ol' buy rating -- seeing as it thinks the stock is worth $28, and Cliffs only costs $17 and change today.
Top 5 Paper Companies To Invest In Right Now: McKesson Corp (MCK)
McKesson Corporation, incorporated on July 7, 1994, delivers pharmaceuticals, medical supplies and healthcare information technologies. The Company operates in two segments: McKesson Distribution Solutions segment and McKesson Technology Solutions segment. The McKesson Distribution Solutions segment distributes drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. The McKesson Technology Solutions segment delivers enterprise clinical, patient care, financial, supply chain, strategic management software solutions, pharmacy automation for hospitals, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. In February 2013, the Company completed acquisition of Pss World Medical Inc. In February 2014, McKesson Corporation announced that its ownership in Celesio AG exceeds 75% interest.
Distribution Solutions
McKesson Distribution Solutions consists of the businesses, which include United States Pharmaceutical Distribution, McKesson Canada, Medical-Surgical Distribution, McKesson Specialty Health and McKesson Pharmacy Systems and Automation. United States Pharmaceutical Distribution business supplies pharmaceuticals and/or other healthcare-related products to customers in three primary customer channels: retail national accounts (including national and regional chains, food/drug combinations, mail order pharmacies and mass merchandisers); independent retail pharmacies, and institutional healthcare providers (including hospitals, health systems, integrated delivery networks, clinics and alternate site providers). This business also provides solutions and services to pharmaceutical manufacturers. This business sources materials and products from a range of different suppliers, including the production of certain generic pharmaceutical drugs through a contract-manufacturing program.
The Company�� United States pharmaceutical distribution b! usiness operates and serves thousands of customer locations through a network of 28 distribution centers, as well as a primary redistribution center, a strategic redistribution center and two repackaging facilities, serving all 50 states and Puerto Rico. It invests in technology and other systems at all of its distribution centers to enhance safety and reliability and provide the product availability for its customers. In addition, it offers Mobile ManagerSM, which integrates portable handheld technology with Acumax Plus to give customers complete ordering and inventory control. The Company also offers McKesson ConnectSM, an Internet-based ordering system that provides item lookup and real-time inventory availability, as well as ordering, purchasing, third-party reconciliation and account management functionality. Together, these features help ensure customers have the right products at the right time for their facilities and patients.
The offerings of the McKesson United States Pharmaceutical Distribution business by customer group can be categorized as retail national accounts, independent retail pharmacies and institutional healthcare providers. Retail National Accounts is a business solutions that help national account customers increase revenues and profitability. Solutions include Central Fill, Redistribution Centers, EnterpriseRx, RxPak, Inventory Management, McKesson OneStop Generics and ExpressRx Track.
Independent Retail Pharmacies is a solutions for managed care contracting, branding and advertising, merchandising, purchasing, operational efficiency and automation that help independent pharmacists focus on patient care while improving profitability. Solutions include Health Mart, AccessHealth, McKesson Reimbursement Advantage, McKesson OneStop Generics, EnterpriseRx, Sunmark, FrontEdge and McKesson Sponsored Clinical Services (SCS) Network. Institutional Healthcare Providers is a electronic ordering/purchasing and supply chain management systems that help customers ! improve f! inancial performance, increase operational efficiencies and deliver better patient care. Solutions include McKesson Pharmacy Optimization, Fulfill-Rx, Asset Management, SKY Packaging, McKesson Plasma and BioLogics, McKesson OneStop Generics and McKesson 340B Solution Suite and Macro Helix.
Medical-Surgical Distribution business provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers including physicians' offices, surgery centers, extended care facilities, homecare and occupational health sites through a network of distribution centers within the United States. This business is a provider of supplies to the full range of alternate-site healthcare facilities, including physicians' offices, clinics and surgery centers (primary care), long-term care, occupational health facilities and homecare sites (extended care). McKesson Specialty Health business provides solutions for oncology and other specialty practices operating in communities across the country, as well as for pharmaceutical and biotech suppliers who manufacture specialty drugs and vaccines.
The Company provides direct-to-physician specialty distribution services, ensuring supply chain safety and delivery of specialty drugs in manufacturer recommended conditions. Third party logistics (3PL), are offered primarily for vaccine distribution, including its exclusive distributor relationship in the Centers for Disease Control and Prevention's (CDC) Vaccines for Children program. The Company also offer its industry Lynx integrated technologies, the iKnowMed Electronic Health Record, and clinical and practice management tools, all of which help community practices improve inventory management, practice workflow and reimbursement processes, as well as deliver business efficiencies and clinical-decision support. McKesson Specialty Health works with manufacturers across all phases of the product development and commercialization lifecycle, including clinical research, to optim! ize deliv! ery of complex medication to patients.
McKesson Pharmacy Systems and Automation business supplies integrated pharmacy management systems, automated dispensing systems and related services to retail, outpatient, central fill, specialty and mail order pharmacies. Its primary approach is to provide the customer with a pharmacy management system that suits the particular needs of their business operation.
Technology Solutions
The Company�� Technology Solutions segment provides a portfolio of software, automation, support and services to help healthcare organizations. This segment also includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. Technology Solutions markets its products and services to integrated delivery networks, hospitals, physician practices, home healthcare providers, retail pharmacies and payers. The product portfolio for the Technology Solutions segment is designed to address a range of healthcare clinical and business performance needs ranging from medication safety and information access to revenue cycle management, resource utilization and physician adoption of electronic health records (EHR). Technology Solutions consists of businesses, which include McKesson Health Solutions, Enterprise Medical Imaging and Ancillary Solutions, RelayHealth, Revenue Management Solutions, Enterprise Information Solutions, Hospital Automation and International Technology.
McKesson Health Solutions services and software products is designed to manage the cost and quality of care for payers, providers, hospitals and government organizations. Solution sets include InterQual Criteria for clinical decision support and utilization management; Claims payment solutions to facilitate accurate and efficient medical claim payments; Business intelligence tools for measuring, reporting and improving clinical and financial performance; Network management tools to enable health plans to transform the performance of ! their net! works, and RelayHealth financial solutions to facilitate communication between healthcare providers and patient aggregate data for claims management and trend analysis, and optimize revenue cycle management processes.
The Company offers medical imaging and information management systems for healthcare enterprises, including a picture archiving communications system, a radiology information system and a cardiovascular information system. The Company�� enterprise approach to medical imaging enables organizations to take advantage of specialty-specific workstations, while building an integrated image repository that manages all of the images and information captured throughout the care continuum. Through its vendor-neutral RelayHealth and its intelligent network, the Company provides health information exchange solutions that streamline clinical and administrative communication between patients, providers, payers, pharmacies, manufacturers, government and financial institutions. RelayHealth helps to accelerate the delivery of care and improve financial performance through online consultation of physicians by patients, electronic prescribing by physicians, and point-of-service resolution of pharmacy claims by payers.
The Company help providers focus their resources on delivering healthcare while managing their revenue cycle operations and information technology through a suite of managed services. Services include full and partial revenue cycle outsourcing, remote hosting and business office administration. The Company also provides a solution for physician practices of all sizes, whether they are independent or employed, that includes software, revenue cycle outsourcing and connectivity services. Software solutions include practice management and EHR software for physicians of every size and specialty. The Company provides clinical and financial information systems for hospitals and health systems of all sizes. These systems are designed to improve the safety and quality of pati! ent care ! and improve clinical, financial and operational performance. Clinical functionality includes a data repository, care planning, physician order entry and documentation, nursing documentation with bar-coded medication administration, pharmacy, surgical management, emergency department and ambulatory EHR systems, and a Web-based physician portal. Automation solutions include technologies that help hospitals re-engineer and improve their medication use processes. The Company provides patient administration systems and clinical products to health and social care systems of all sizes in the United Kingdom and other European countries.
Advisors' Opinion:- [By Laura Brodbeck]
Thursday
Earnings Expected From: Exxon Mobil Corporation (NYSE: XOM), McKesson Corporation (NYSE: MCK), ConocoPhillips (NYSE: COP), Anheuser-Busch Inbev SA (NYSE: BUD), DIRECTV (NASDAQ: DTV), AstraZeneca PLC (NYSE: AZN) Economic Releases Expected: Japanese manufacturing PMI, eurozone CPI, Spanish current account, eurozone unemployment rate, Italian CPI, French PPI, German retail salesFriday
- [By Dividends4Life]
Memberships and Peers: CAH is a member of the S&P 500, a Dividend Aristocrat and a member of the Broad Dividend Achievers��Index. The company's peer group includes: AmerisourceBergen Corporation (ABC) with a 1.3% yield, McKesson Corporation (MCK) with a 0.6% yield and Owens & Minor Inc. (OMI) with a 2.5% yield.
5 Best High Tech Stocks To Buy Right Now: Polydex Pharmaceuticals Ltd (POLXF.PK)
Polydex Pharmaceuticals Limited, incorporated on June 14, 1979, is engaged in the research, development, manufacture and marketing of biotechnology-based products for the human pharmaceutical market. The Company also manufactures bulk pharmaceutical intermediates for the global veterinary pharmaceutical industry. It focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The products of the Company include Iron Dextran and Dextran Sulphate. The wholly owned subsidiaries of the Company include Dextran Products Limited (Dextran Products) and Chemdex Inc (Chemdex).
Iron Dextran
Iron Dextran is a derivative of Dextran produced by complexing iron with Dextran. Iron Dextran is injected into pigs at birth as a treatment for anemia. The Company sells Iron Dextran to independent distributors and wholesalers in Europe, the Far East and Canada. Chemdex, Inc. has United States FDA approval for the manufacture and sale of Iron Dextran for veterinary use.
Dextran Sulphate
Dextran Sulphate is a specialty chemical derivative of Dextran used in research applications by the pharmaceutical industry and other centers of chemical research. Dextran Sulphate manufactured by the Company is sold primarily to independent distributors and wholesalers in the United States and Europe as analytical chemical applications.
Advisors' Opinion:- [By The GeoTeam]
Polydex Pharmaceuticals (POLXF.PK) Limited, through its subsidiaries, engages in the development, manufacture, and marketing of biotechnology-based products for the human pharmaceutical market. It is also involved with manufacture of bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It primarily offers Dextran and Dextran derivative products.
5 Best High Tech Stocks To Buy Right Now: Carmike Cinemas Inc.(CKEC)
Carmike Cinemas, Inc. operates as a digital cinema and 3D motion picture exhibitor in the United States. It operates theatres that show films on a first-run basis; and discount theatres. The company serves small to mid-size non-urban markets. As of December 31, 2011, it owned, operated, or had an interest in 237 theatres with 2,254 screens located in 35 states. The company was founded in 1982 and is headquartered in Columbus, Georgia.
Advisors' Opinion:- [By Jon Friedman]
Wible's analysis determines that the beneficiaries are likely going to be Viacom (NASDAQ: VIAB ) , Lions Gate, Carmike Cinemas (NASDAQ: CKEC ) , and DIRECTV (NASDAQ: DTV ) .
- [By Chad Fraser] Christmas is a time for good cheer, reflection and spending time with friends and family. Here are four stocks that reflect the season, ranging from Christmas tree providers to toymakers and beyond:
Weyerhaeuser (NYSE: WY): Some little-known Christmas tree facts: there are 25 million to 30 million sold in the U.S. every year, with about 350 million currently growing in the country. It takes an average of seven years to grow a Christmas tree to its proper height.
Most Christmas tree farms are privately owned, but they need to get good seedlings from somewhere, so many turn to timber company Weyerhaeuser, which grows the most popular species—including balsam fir, Douglas fir, Scotch pine and white pine.
Weyerhaeuser controls about 6 million acres of timberland, with about a third of that in the Pacific Northwest, which is America’s most prolific lumber-producing region thanks to its cool, damp climate and considerable rainfall.
“The fact that it’s the largest timber producer in the Pacific Northwest makes Weyerhaeuser extremely attractive, because the company’s location gives it easy export access to China,” wrote Investing Daily analyst Benjamin Shepherd in a December 13 article. “This location also leaves it well-placed to pick up the supply slack created by lower production caps in Canada, which is typically a key Chinese supplier.”
Mattel (NYSE: MAT) is proving that the most traditional toys you can think of—dolls—still have a place under the tree, even in the digital age. As we reported on October 16, Mattel’s doll lineup was the main reason why its third-quarter earnings surged past Wall Street estimates.
The company’s strength is centered on its ability to come up with popular new dolls while reimagining the tried-and-true. Right now, its Monster High franchise, which it rolled out in 2010, is stealing the show: the brand’s p - [By Michael Lewis]
With the $175 million Iron Man 3 opening weekend just passed, it may be hard to remember that the first quarter of this year was a rough one for the movie business. Weak theater attendance and a lack of big-draw films made it an ugly quarter for studios and theaters alike. Carmike Cinemas (NASDAQ: CKEC ) was no exception. Especially frustrating was that this year's weak quarter follows Carmike's record first quarter from 2012. Long term, though, this is a growing company that is well managed and holds a lucrative niche spot in the competitive, low-margin theater business. Here's what you need to know about Carmike Cinemas.
5 Best High Tech Stocks To Buy Right Now: LRR Energy LP (LRE)
LRR Energy, L.P (LRR Energy) is a limited partnership formed by affiliates of Lime Rock Resources to operate, acquire, exploit and develop producing oil and natural gas properties in North America. The Company�� properties are located in the Permian Basin region in West Texas and southeast New Mexico, the Mid-Continent region in Oklahoma and East Texas and the Gulf Coast region in Texas. As of March 31, 2011, the Company�� total estimated proved reserves were approximately 30.3 million barrels of oil equivalent (MMBoe), of which approximately 84% were proved developed reserves. During the year ended December 31, 2010, approximately 55% of its pro forma revenues were from oil and natural gas liquids (NGLs) and approximately 37% of its total estimated proved reserves were oil and NGLs. As of March 31, 2011, the Company operated 93% of its proved reserves. Based on its pro forma average net production of 6,503 barrels of oil equivalent per day (Boe/d) for December 31, 2010, the Company�� total estimated proved reserves as of March 31, 2011 had a reserve-to-production ratio of approximately 12.8 years. In January 2013, the Company acquired oil and natural gas properties in the Mid-Continent region in Oklahoma from its sponsor, Lime Rock Resources. In April 2013, it announced that it closed its acquisition of oil and natural gas properties in the Mid-Continent region in Oklahoma.
The Company�� general partner, LRE GP, LLC, is controlled by Lime Rock Management LP. The Company�� general partner has sole responsibility for conducting its business and for managing its operations. The Company�� properties consist of mature, low-risk onshore oil and natural gas reservoirs with long-lived, predictable production profiles located across three diverse producing regions: the permian basin region in west texas and southeast new mexico, the mid-continent region in oklahoma and east texas, and the gulf coast region in texas. As of March 31, 2011, the Company�� estimated proved developed non-! producing reserves included 192 gross (158 net) recompletion, refracture stimulation and workover projects. In addition, as of March 31, 2011, the Company�� proved undeveloped reserves included 213 gross (140 net) identified drilling locations.
As of March 31, 2011, approximately 55% of the Company�� estimated proved reserves and approximately 44% of its pro forma average daily net production for the three months ended December 31, 2010, were located in the Permian Basin region. Approximately 60% of the Company�� estimated net proved reserves in the Permian Basin region are oil and NGLs. The Permian Basin is one of the oil and natural gas producing basins in the United States, extending over 100,000 square miles in West Texas and southeast New Mexico, and has produced over 24 billion barrels of oil. The Company owns an 83% average working interest across 665 gross (552 net) wells and operates approximately 92% of its properties in the Permian Basin. The Company�� estimated proved reserves for its Permian Basin properties as of March 31, 2011 totaled 16.6 MMBoe and had a standardized measure of $237.7 million, which represented 69% of the total standardized measure for all of its estimated proved reserves.
The Company�� properties in the Red Lake area is an oil-weighted field located in Eddy County, New Mexico. The Red Lake properties have produced approximately 4.9 MMBoe. The primary producing formations are the San Andres and Yeso at a depth of approximately 2,000 to 5,000 feet. The Company operates approximately 99% of its proved reserves in the Red Lake area, including 157 gross (144 net) producing wells in the field with an average working interest of 92%, and own a non-operated working interest in 10 gross (3 net) additional wells in the area with an average working interest of 31%. The Company�� properties in the field contained 9.6 MMBoe of estimated net proved reserves as of March 31, 2011, approximately 86% of which are oil and NGLs, and generated average n! et produc! tion of 1,410 Boe/d for December 31, 2010. These properties represented 32% of its total estimated proved reserves as of March 31, 2011 and 22% of the Company�� pro forma average net production for December 31, 2010. In addition, these properties had a standardized measure of $163.3 million as of March 31, 2011, which represented 48% of the total standardized measure for all of the Company�� estimated proved reserves.
The Company�� properties in the Pecos Slope area is a gas-weighted field located in Eddy, Chaves, Lea and Roosevelt Counties, New Mexico. The Company operates approximately 100% of its proved reserves in the Pecos Slope area, including 434 gross (382 net) producing wells in the field with an average working interest of 88%. The Company�� Willow Lake field is an oil-weighted field located in Eddy County, New Mexico. There are 41 gross (8 net) producing wells in this area with an average non-operated working interest of 19%. The Cowden Ranch area is an oil-weighted field located in Crane County, Texas. The Company operate s100% of its proved reserves in the Cowden Ranch area, including 8 gross (approximately 5 net) producing wells in the field with an average working interest of 71%. The Company�� properties in the Corbin and Vacuum have produced approximately 3.0 MMBoe. The Company operates 100% of its proved reserves in the Corbin and Vacuum areas, including 8 gross (8 net) producing wells with an average working interest of 100%.
As of December 31, 2010, approximately 33% of the Company�� estimated proved reserves and approximately 38% of its pro forma average daily net production for December 31, 2010 were located in the Mid-Continent region. The Company�� Potato Hills Area is an Arkoma Basin natural gas property located in Latimer and Pushmataha Counties in Southeast Oklahoma. The Company�� Reklaw properties have produced approximately 5.6 MMBoe. The Company operates 100% of its proved reserves in the Reklaw area, including 63 gross (61 net) pro! ducing we! lls in the field with an average working interest of 97%. Its properties in the Black Bayou-Doyle Creek area is a natural gas-weighted field located in Angelina, Cherokee and Nacogdoches Counties, Texas, in close proximity to the Reklaw area. The Company�� non-operated interest in 43 gross (approximately 12 net) producing wells in the field with an average non-operated working interest of 26%.
As of March 31, 2011, approximately 12% of the Company�� estimated proved reserves and approximately 18% of its pro forma average daily net production for December 31, 2010 were located in the Gulf Coast region. Approximately 31% of the Company�� estimated net proved reserves in the Gulf Coast region are oil and NGLs. The Company owns an 82% average working interest across 42 gross (35 net) wells and operates 100% of its properties in the Gulf Coast region. The Company�� property New Years Ridge area is a natural gas-weighted field located in DeWitt County, Texas. The Company�� George West-Stratton areas consist of natural gas-weighted fields located in Live Oak and Hidalgo Counties, Texas. The Company�� operates 100% of its proved reserves in the George West-Stratton areas, including 23 gross (17 net) producing wells in the George West-Stratton areas with an average working interest of 73%.
Advisors' Opinion:- [By Travis Hoium]
What: Shares of LRR Energy (NYSE: LRE ) dropped as much as 10% today after the company released earnings.
So what: Revenue dropped nearly 50%, to $15.8 million, and the company swung to a loss of $7.5 million, or $0.32 per share. Analysts had expected $28.4 million in revenue, and earnings of $0.13 per share.�
No comments:
Post a Comment